Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@StocksFtr](/creator/twitter/StocksFtr)
"Diagnostics are gaining attention putting Exact Sciences on the radar. The company's path to sustainable profitability not just revenue growth remains a key focus for investors. #EXAS #HealthTech #XBI"  
[X Link](https://x.com/StocksFtr/status/1980069006389158231) [@StocksFtr](/creator/x/StocksFtr) 2025-10-20T00:30Z XXX followers, XX engagements


"As biotech sentiment shifts Ionis is expanding its pipeline. This requires significant R&D investment which can strain finances before any potential revenue is generated. #IONS #XBI #Innovation"  
[X Link](https://x.com/StocksFtr/status/1980069008725406034) [@StocksFtr](/creator/x/StocksFtr) 2025-10-20T00:30Z XXX followers, XX engagements


"Exact Sciences is leveraging data to enhance its diagnostic tools. This is a capital-intensive strategy and its long-term return on investment is still being evaluated. #EXAS #DataDriven #Healthcare"  
[X Link](https://x.com/StocksFtr/status/1980069010382135702) [@StocksFtr](/creator/x/StocksFtr) 2025-10-20T00:30Z XXX followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@StocksFtr "Diagnostics are gaining attention putting Exact Sciences on the radar. The company's path to sustainable profitability not just revenue growth remains a key focus for investors. #EXAS #HealthTech #XBI"
X Link @StocksFtr 2025-10-20T00:30Z XXX followers, XX engagements

"As biotech sentiment shifts Ionis is expanding its pipeline. This requires significant R&D investment which can strain finances before any potential revenue is generated. #IONS #XBI #Innovation"
X Link @StocksFtr 2025-10-20T00:30Z XXX followers, XX engagements

"Exact Sciences is leveraging data to enhance its diagnostic tools. This is a capital-intensive strategy and its long-term return on investment is still being evaluated. #EXAS #DataDriven #Healthcare"
X Link @StocksFtr 2025-10-20T00:30Z XXX followers, XX engagements

creator/twitter::1678834756761567232/posts
/creator/twitter::1678834756761567232/posts